🌍 MBBS · subject

MBBS Anesthasia Syllabus

The Anesthasia syllabus for MBBS in full: 10 chapters, 27 topics and 70 sub-topics, every one listed below, plus 51 Anesthasia flashcards with answers.

10Chapters
27Topics
70Sub-topics
51Flashcards

Anesthasia syllabus: all 10 chapters

Expand any chapter to see its topics and sub-topics.

  1. Introduction to Anesthesia

    2 topics
    • History of Anesthesia
      • Evolution of anesthesia techniques and drugs
    • Principles of Anesthesia
      • Goals of anesthesia (analgesia, amnesia, muscle relaxation, and homeostasis)
      • Stages of anesthesia
      • Monitoring techniques
  2. Preoperative Evaluation

    3 topics
    • Preoperative assessment
      • Patient history (medical, surgical, and anesthesia history), physical examination, and laboratory investigations
    • Assessment of comorbidities
      • Cardiovascular, respiratory, renal, hepatic, and endocrine disorders
    • Optimization of medical conditions
      • Preoperative medication management, control of hypertension, diabetes, and other systemic diseases
  3. Anesthetic Pharmacology

    3 topics
    • General Anesthetics
      • Inhalational Anesthetics
      • Intravenous Anesthetics
      • Adjunctive Drugs
    • Local Anesthetics
      • Mechanism of Action
      • Pharmacokinetics
      • Types
      • Adverse Effects
    • Neuromuscular Blocking Agents
      • Depolarizing Agents
      • Non-Depolarizing Agents
  4. Anesthetic Techniques

    3 topics
    • General anesthesia
      • Inhalational anesthesia
      • Intravenous anesthesia
      • Balanced anesthesia techniques
    • Regional anesthesia
      • Spinal anesthesia
      • Epidural anesthesia
      • Peripheral nerve blocks
      • Local infiltration anesthesia
    • Monitored anesthesia care (MAC)
      • Sedation techniques for conscious sedation during minor procedures
  5. Airway Management

    3 topics
    • Endotracheal Intubation
      • Indications
      • Equipment
      • Techniques
      • Complications
    • Supraglottic Airway Devices
      • Laryngeal Mask Airway (LMA)
      • Intubating LMA
      • Complications
    • Difficult Airway Management
      • Recognition of Difficult Airway
      • Strategies
      • Emergency Airway Algorithms
  6. Anesthetic Complications

    3 topics
    • Hypotension
      • Causes
      • Diagnosis
      • Management
    • Hypoxemia
      • Causes
      • Diagnosis
      • Management
    • Malignant hyperthermia
      • Pathophysiology
      • Clinical features
      • Diagnosis
      • Management
  7. Postoperative Care

    2 topics
    • Post-anesthesia care unit (PACU)
      • Monitoring (vital signs, pain assessment)
      • Management of postoperative complications (pain, nausea, vomiting)
      • Discharge criteria
    • Pain management
      • Analgesic techniques (opioids, nonsteroidal anti-inflammatory drugs)
      • Patient-controlled analgesia (PCA)
      • Regional anesthesia techniques for postoperative pain relief
  8. Special Situations in Anesthesia

    3 topics
    • Pediatric Anesthesia
      • Anesthetic considerations in children (dose calculation, airway management)
      • Management of congenital abnormalities
    • Obstetric Anesthesia
      • Anesthesia techniques for cesarean section (spinal anesthesia, epidural anesthesia)
      • Management of preeclampsia
      • Fetal monitoring
    • Geriatric Anesthesia
      • Anesthetic considerations in elderly patients (physiological changes, comorbidities)
      • Management of postoperative delirium
  9. Anesthesia for Specific Surgical Procedures

    3 topics
    • Cardiothoracic anesthesia
      • Anesthetic management for coronary artery bypass grafting (CABG)
      • Anesthetic management for valve replacement
      • Anesthetic management for thoracic surgery
    • Neurosurgical anesthesia
      • Anesthetic considerations for craniotomy
      • Anesthetic considerations for intracranial aneurysm clipping
      • Anesthetic considerations for spinal surgery
    • Orthopedic anesthesia
      • Anesthetic techniques for joint replacement surgery (total hip arthroplasty)
      • Anesthetic techniques for joint replacement surgery (total knee arthroplasty)
      • Management of acute pain
  10. Emerging Trends in Anesthesia

    2 topics
    • Enhanced Recovery after Surgery (ERAS)
      • Multimodal perioperative care pathways to optimize patient outcomes and reduce length of hospital stay
    • Point-of-Care Ultrasound (POCUS)
      • Use of ultrasound for vascular access
      • Use of ultrasound for nerve localization
      • Use of ultrasound for diagnosis of pneumothorax during anesthesia

MBBS Anesthasia flashcards — 51 questions with answers

  1. Who is credited with the first successful public demonstration of ether anesthesia, and where and when did it take place?

    William T. G. Morton demonstrated ether anesthesia on October 16, 1846 ("Ether Day") at the Massachusetts General Hospital, Boston, removing a neck tumor from patient Gilbert Abbott in an amphitheater later named the "Ether Dome."

  2. Which physician first used the term "anaesthesia," and which agent did James Young Simpson introduce in 1847?

    Oliver Wendell Holmes proposed the term "anaesthesia" in 1846. James Young Simpson introduced chloroform for obstetric and surgical anesthesia in 1847.

  3. What are the three core components (the "triad") of balanced general anesthesia?

    The triad is (1) hypnosis/unconsciousness (amnesia), (2) analgesia (pain control), and (3) muscle relaxation (areflexia/akinesia), often supplemented by control of autonomic responses.

  4. What are the four classic Guedel stages of ether anesthesia?

    Stage I: analgesia (induction to loss of consciousness). Stage II: excitement/delirium (loss of consciousness to onset of automatic breathing). Stage III: surgical anesthesia (4 planes). Stage IV: medullary/respiratory paralysis (overdose, leading to death if not reversed).

  5. What does the ASA Physical Status (ASA-PS) classification I through VI describe?

    ASA I: normal healthy patient. ASA II: mild systemic disease. ASA III: severe systemic disease. ASA IV: severe systemic disease that is a constant threat to life. ASA V: moribund, not expected to survive without the operation. ASA VI: declared brain-dead organ donor. The suffix "E" denotes emergency surgery.

  6. Define the Minimum Alveolar Concentration (MAC) of an inhalational anesthetic.

    MAC is the alveolar concentration of an inhaled anesthetic (at 1 atm) that prevents movement in response to a surgical (skin) incision in 50% of subjects. It is a measure of anesthetic potency: lower MAC means higher potency.

  7. List the approximate MAC values (in % atm) of nitrous oxide, sevoflurane, isoflurane, and desflurane.

    Nitrous oxide $\approx 104\%$, desflurane $\approx 6\%$, sevoflurane $\approx 2\%$, isoflurane $\approx 1.2\%$, halothane $\approx 0.75\%$. Lower MAC = more potent.

  8. Name at least four physiological/clinical factors that INCREASE MAC (raise anesthetic requirement).

    Factors that increase MAC: hyperthermia, chronic alcohol use, acute amphetamine/cocaine use, hypernatremia, red hair, infancy (peak around 6 months), and CNS stimulants.

  9. Name at least four factors that DECREASE MAC (lower anesthetic requirement).

    Factors that decrease MAC: increasing age (elderly), hypothermia, pregnancy, hypotension/anemia, hypoxia, opioids and other sedatives, acute alcohol intoxication, lithium, $\alpha_2$-agonists (clonidine/dexmedetomidine), and hyponatremia.

  10. What is the Meyer-Overton correlation regarding inhalational anesthetic potency?

    The Meyer-Overton rule states anesthetic potency correlates directly with lipid solubility: the more lipid-soluble (higher oil:gas partition coefficient) an agent, the lower its MAC and the greater its potency.

  11. What does the blood:gas partition coefficient of an inhalational agent determine?

    It determines speed of induction and recovery. A LOW blood:gas coefficient (e.g., desflurane 0.42, nitrous oxide 0.46) means low solubility, faster equilibration, and rapid onset/offset. A HIGH coefficient (e.g., halothane 2.4) means slower induction and recovery.

  12. What is the standard induction dose of IV propofol, and what is its most notable cardiovascular side effect?

    Propofol induction dose is approximately $1.5\text{--}2.5\ \mathrm{mg/kg}$ IV. Its most notable side effect is dose-dependent hypotension (from decreased systemic vascular resistance and myocardial depression), plus apnea and pain on injection.

  13. Which IV induction agent best preserves hemodynamic stability, and what endocrine side effect limits its repeated use?

    Etomidate (induction dose $\approx 0.3\ \mathrm{mg/kg}$) preserves cardiovascular stability, making it useful in shock/cardiac patients. It causes adrenocortical suppression (inhibits $11\beta$-hydroxylase), so continuous infusion/repeated dosing is avoided. It also causes myoclonus and high incidence of PONV.

  14. What is the mechanism and key clinical feature of ketamine anesthesia?

    Ketamine is an NMDA receptor antagonist producing "dissociative anesthesia" with profound analgesia and amnesia. It maintains airway reflexes and respiration, is a bronchodilator, and raises BP/HR (sympathomimetic). Side effects include emergence delirium/hallucinations and increased secretions.

  15. What is the mechanism of action common to most general anesthetics and benzodiazepines at the GABA receptor?

    Most IV anesthetics (propofol, etomidate, barbiturates) and benzodiazepines potentiate the inhibitory $\mathrm{GABA_A}$ receptor, increasing chloride conductance and hyperpolarizing neurons. Benzodiazepines increase the FREQUENCY of channel opening; barbiturates increase the DURATION of channel opening.

  16. What chemical property distinguishes ester from amide local anesthetics, and how can amide LAs be remembered?

    Esters have one "i" in the name and are metabolized by plasma pseudocholinesterase (producing PABA, higher allergy risk). Amides have two "i"s in the name (e.g., lIdocaIne, bupIvacaIne) and are metabolized by the liver.

  17. What is the mechanism of action of local anesthetics?

    Local anesthetics reversibly block voltage-gated $\mathrm{Na^{+}}$ channels from the intracellular side, preventing membrane depolarization and propagation of the action potential. They preferentially bind channels in the open/inactivated state (use-dependent block).

  18. In what order are nerve fiber functions typically lost during local anesthetic blockade?

    Order of loss: autonomic (B fibers) $\to$ pain and temperature $\to$ touch $\to$ pressure $\to$ motor function. Smaller, myelinated fibers are blocked before large fibers; recovery occurs in reverse order.

  19. State the maximum safe dose of lidocaine with and without epinephrine.

    Lidocaine maximum dose: $\approx 4.5\ \mathrm{mg/kg}$ (up to $300\ \mathrm{mg}$) WITHOUT epinephrine, and $\approx 7\ \mathrm{mg/kg}$ (up to $500\ \mathrm{mg}$) WITH epinephrine (which prolongs action and reduces systemic absorption).

  20. What is Local Anesthetic Systemic Toxicity (LAST), and what is its specific antidote/treatment?

    LAST results from excessive plasma LA levels, causing CNS signs (perioral numbness, tinnitus, seizures) progressing to cardiovascular collapse (bupivacaine is especially cardiotoxic). Treatment: stop injection, ABCs, and give 20% intravenous lipid emulsion ("lipid rescue").

Show the other 31 Anesthasia flashcards
  1. Why is epinephrine contraindicated in local anesthesia of end-arterial regions (fingers, toes, nose, penis, ears)?

    Epinephrine causes vasoconstriction of end-arteries with no collateral supply, risking ischemia and tissue necrosis. The traditional teaching is to avoid epinephrine in "fingers, toes, nose, penis, and ears" (end-organs).

  2. Compare depolarizing vs non-depolarizing neuromuscular blockers by mechanism and the prototype of each.

    Depolarizing (prototype succinylcholine): an acetylcholine receptor AGONIST that causes persistent depolarization (initial fasciculations then flaccid paralysis); NOT reversed by neostigmine. Non-depolarizing (e.g., rocuronium, vecuronium, atracurium): competitive ACh receptor ANTAGONISTS, reversed by anticholinesterases or sugammadex.

  3. What makes succinylcholine the fastest-onset, shortest-acting NMBA, and what enzyme terminates its action?

    Succinylcholine has rapid onset ($30\text{--}60$ s) and short duration ($5\text{--}10$ min), ideal for rapid sequence intubation. It is metabolized by plasma pseudocholinesterase (butyrylcholinesterase); deficiency or atypical enzyme causes prolonged paralysis.

  4. List the major adverse effects/contraindications of succinylcholine.

    Succinylcholine can cause hyperkalemia (dangerous in burns, crush injury, denervation, prolonged immobility), malignant hyperthermia trigger, bradycardia (especially in children/repeat doses), increased intraocular/intracranial/intragastric pressure, myalgias, and prolonged apnea with pseudocholinesterase deficiency.

  5. How does sugammadex reverse neuromuscular blockade, and which agents does it target?

    Sugammadex is a modified $\gamma$-cyclodextrin that encapsulates (chelates) aminosteroid NMBAs in plasma, forming an inactive complex that is renally excreted. It rapidly reverses rocuronium and vecuronium (not benzylisoquinoliniums like atracurium).

  6. By what unique organ-independent pathway is atracurium (and cisatracurium) eliminated, and why is this useful?

    Atracurium/cisatracurium undergo Hofmann elimination (spontaneous, temperature- and pH-dependent non-enzymatic degradation) plus ester hydrolysis. This is independent of hepatic and renal function, making them ideal in liver or kidney failure.

  7. What is the standard reversal regimen for non-depolarizing blockade using an anticholinesterase, and why is an antimuscarinic added?

    Neostigmine (an acetylcholinesterase inhibitor) increases ACh at the junction to overcome the block. It is co-administered with an antimuscarinic (glycopyrrolate or atropine) to prevent muscarinic side effects such as bradycardia, salivation, and bronchospasm.

  8. What does the Train-of-Four (TOF) ratio assess, and what TOF ratio indicates adequate recovery from neuromuscular blockade?

    TOF delivers four supramaximal stimuli at 2 Hz; the TOF ratio is the amplitude of the 4th twitch divided by the 1st ($T4/T1$). A TOF ratio $\geq 0.9$ indicates adequate recovery and is the accepted threshold for safe extubation.

  9. What is the Mallampati classification used for, and what do Classes I and IV indicate?

    The Mallampati classification predicts difficulty of laryngoscopy/intubation based on visible oropharyngeal structures. Class I: soft palate, uvula, fauces, and pillars visible (easy). Class IV: only hard palate visible (predicts difficult intubation).

  10. What is the mnemonic LEMON for difficult airway assessment?

    LEMON: L = Look externally (facial trauma, beard, obesity), E = Evaluate the 3-3-2 rule, M = Mallampati score, O = Obstruction/Obesity, N = Neck mobility.

  11. Explain the 3-3-2 rule for airway assessment.

    The 3-3-2 rule predicts ease of laryngoscopy: 3 fingerbreadths mouth opening (inter-incisor distance), 3 fingerbreadths from chin (mentum) to hyoid bone, and 2 fingerbreadths from floor of mouth (hyoid) to thyroid notch. Failure to meet these suggests a difficult airway.

  12. What is the most reliable confirmation of correct endotracheal tube placement?

    Sustained waveform capnography (detection of exhaled $\ce{CO2}$ over $\geq 6$ breaths / continuous $\mathrm{ETCO_2}$) is the gold standard for confirming tracheal (not esophageal) placement, supplemented by bilateral chest auscultation, chest rise, and misting of the tube.

  13. What are typical endotracheal tube internal diameter (ID) sizes for an average adult male and female?

    Average adult male: ETT internal diameter $7.5\text{--}8.5\ \mathrm{mm}$; average adult female: $7.0\text{--}8.0\ \mathrm{mm}$. For children $>1$ year (uncuffed): $\text{ID} = \dfrac{\text{age}}{4} + 4\ \mathrm{mm}$.

  14. What is the recommended endotracheal cuff pressure range, and why does it matter?

    Cuff pressure should be kept at $20\text{--}30\ \mathrm{cmH_2O}$. Too high risks tracheal mucosal ischemia/necrosis and stenosis; too low allows aspiration and gas leak. Pressure should remain below tracheal capillary perfusion pressure ($\approx 25\text{--}35\ \mathrm{mmHg}$).

  15. What is a supraglottic airway device (e.g., LMA), and where does it sit?

    A supraglottic airway (e.g., laryngeal mask airway) is placed blindly in the hypopharynx with a cuff that seals around the laryngeal inlet (above the glottis), providing ventilation WITHOUT passing through the vocal cords. It is used for spontaneous or controlled ventilation in selected cases and as a difficult-airway rescue.

  16. Name the main limitations/contraindications of a classic LMA compared with an endotracheal tube.

    LMA does NOT provide a definitive sealed airway: it gives limited protection against aspiration, so it is relatively contraindicated in full stomach/high aspiration risk, morbid obesity, poor lung compliance, and surgery requiring high airway pressures or prone/lateral positioning.

  17. According to difficult airway algorithms, what is the over-arching priority when intubation fails?

    The priority is always oxygenation/ventilation, not intubation. The mantra is to avoid the "can't intubate, can't oxygenate" (CICO) catastrophe; if mask ventilation and supraglottic rescue fail, proceed to emergency front-of-neck access (cricothyroidotomy).

  18. In a "can't intubate, can't oxygenate" (CICO) emergency, what is the definitive rescue procedure?

    Emergency front-of-neck airway access, most commonly a cricothyroidotomy (surgical or needle/cannula with jet ventilation) through the cricothyroid membrane, to restore oxygenation when all other techniques have failed.

  19. What is the difference between general anesthesia, regional anesthesia, and monitored anesthesia care (MAC)?

    General anesthesia: drug-induced reversible loss of consciousness with no response even to painful stimuli, often with airway support. Regional anesthesia: LA blocks sensation to a body region (e.g., spinal, epidural, nerve block) while the patient may remain awake. MAC: titrated sedation/analgesia with monitoring, patient breathes spontaneously and can respond, used to supplement local anesthesia.

  20. Contrast spinal (subarachnoid) and epidural anesthesia by site of injection and onset.

    Spinal: LA injected into the CSF in the subarachnoid space (below L2 to avoid the cord); small volume, rapid dense block, fast onset. Epidural: LA injected into the epidural (potential) space; larger volume, slower onset, segmental block, and allows catheter for continuous infusion.

  21. Why must a spinal anesthetic be performed below the L2 vertebral level in adults?

    In adults the spinal cord (conus medullaris) typically terminates at L1-L2, so needle insertion at L3-L4 or L4-L5 (the line between iliac crests = Tuffier's line, $\approx$ L4) avoids cord injury while still reaching CSF of the cauda equina.

  22. What is the classic complication of dural puncture, and how is a post-dural puncture headache (PDPH) characteristically described and treated?

    PDPH results from CSF leak through the dural hole. It is a postural (positional) headache—worse upright, relieved when supine—often frontal/occipital. Treatment: bed rest, hydration, caffeine, analgesics; definitive treatment is an epidural blood patch.

  23. What causes hypotension during spinal/epidural anesthesia and how is it managed?

    Sympathetic blockade causes vasodilation (decreased SVR) and, with high blocks, bradycardia (block of cardiac accelerators $T1\text{--}T4$), reducing preload and cardiac output. Management: IV fluids, vasopressors (phenylephrine, ephedrine), leg elevation, and treating bradycardia with atropine.

  24. Give the formula for mean arterial pressure (MAP) and the formula relating MAP to cardiac output and systemic vascular resistance.

    $$\mathrm{MAP} = \mathrm{DBP} + \frac{1}{3}(\mathrm{SBP} - \mathrm{DBP})$$ and $$\mathrm{MAP} \approx \mathrm{CO} \times \mathrm{SVR}\ (+\ \mathrm{CVP}),\quad \mathrm{CO} = \mathrm{HR} \times \mathrm{SV}.$$

  25. How is intraoperative hypotension commonly defined, and what is a structured framework for its causes?

    Often defined as MAP $< 65\ \mathrm{mmHg}$ or a $>20\%$ drop from baseline. Causes follow the determinants of BP: decreased PRELOAD (hypovolemia, hemorrhage, caval compression), decreased CONTRACTILITY/RATE (anesthetic depression, arrhythmia, MI), and decreased AFTERLOAD/SVR (anaphylaxis, sepsis, sympathectomy, drugs).

  26. Define hypoxemia, and give the alveolar gas equation for predicting alveolar oxygen tension.

    Hypoxemia is low arterial oxygen, typically $\mathrm{PaO_2} < 60\ \mathrm{mmHg}$ or $\mathrm{SpO_2} < 90\%$. Alveolar gas equation: $$P_AO_2 = F_iO_2 (P_{atm} - P_{H_2O}) - \frac{P_aCO_2}{R}$$ where $R \approx 0.8$ and $P_{H_2O} = 47\ \mathrm{mmHg}$ at body temperature.

  27. List the five physiologic mechanisms of hypoxemia.

    (1) Ventilation/perfusion ($\dot V/\dot Q$) mismatch (most common), (2) right-to-left shunt (does not correct with 100% $\ce{O2}$), (3) hypoventilation (raised $\mathrm{PaCO_2}$, normal A-a gradient), (4) diffusion limitation, and (5) low inspired $\ce{O2}$ (high altitude). Calculate the A-a gradient to differentiate.

  28. What is malignant hyperthermia, its triggers, and the underlying genetic defect?

    MH is a life-threatening hypermetabolic crisis of skeletal muscle triggered by volatile anesthetics (halothane, sevoflurane, isoflurane, desflurane) and succinylcholine. It is an autosomal dominant disorder, most often a mutation in the ryanodine receptor ($RYR1$) causing uncontrolled $\mathrm{Ca^{2+}}$ release from the sarcoplasmic reticulum.

  29. What are the early clinical signs of malignant hyperthermia and its specific drug treatment?

    Earliest sign is a rapid rise in $\mathrm{ETCO_2}$ (hypercapnia) with tachycardia, masseter/generalized muscle rigidity, hyperthermia (late), and rhabdomyolysis/hyperkalemia. Treatment: stop triggers, hyperventilate with 100% $\ce{O2}$, and give dantrolene $2.5\ \mathrm{mg/kg}$ IV (repeat to max $10\ \mathrm{mg/kg}$), plus active cooling and correction of acidosis/hyperkalemia.

  30. What are the Aldrete scoring criteria used to assess discharge readiness from the PACU?

    The Aldrete score rates five parameters 0-2 each (max 10): Activity, Respiration, Circulation (BP), Consciousness, and $\ce{O2}$ Saturation (color in the original). A score $\geq 9$ generally indicates readiness for discharge from the post-anesthesia care unit.

  31. What are the most common immediate postoperative complications managed in the PACU, including the major risk factors for PONV?

    Common PACU issues: airway obstruction, hypoxemia, hypotension/hypertension, pain, hypothermia/shivering, emergence delirium, and postoperative nausea and vomiting (PONV). Apfel risk factors for PONV: female sex, non-smoker, history of PONV/motion sickness, and postoperative opioid use.

Same Anesthasia syllabus in other exams

The Anesthasia outline above is identical in these 3 exams:

MBBS Anesthasia FAQ

What is in the MBBS Anesthasia syllabus?

MBBS Anesthasia is split into 10 chapters: Introduction to Anesthesia, Preoperative Evaluation, Anesthetic Pharmacology, Anesthetic Techniques, Airway Management, Anesthetic Complications, Postoperative Care, Special Situations in Anesthesia, Anesthesia for Specific Surgical Procedures and Emerging Trends in Anesthesia. Together they contain 27 topics and 70 sub-topics.

How many chapters are in MBBS Anesthasia?

10 chapters, containing 27 topics and 70 sub-topics. The largest chapter is Preoperative Evaluation, with 3 topics.

Are there flashcards for MBBS Anesthasia?

Yes — a 51-card Anesthasia deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.